InMed Pharmaceuticals Inc. Gains 39.07%
Thu, Mar 24, 2022 at 05:30 PM
InMed Pharmaceuticals Inc. (INM:NASDAQ) shot up at $1.05, representing a gain of 39.1%. On Wed, Mar 23, 2022, INM:NASDAQ touched a New 2-Week Intraday High of $0.84. The stock got featured on our News Catalysts scanner on Tue, Mar 08, 2022 at 07:56 AM in the 'MISCELLANEOUS' category. From Thu, Mar 10, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Wed, Nov 17, 2021 at $2.37 with a volume of 141M+, and its share price has been moving sideways in recent weeks.
About InMed Pharmaceuticals Inc. (INM:NASDAQ)
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company.
Top 10 Gainers:
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 39.07%
- Global Internet of People Inc. (SDH:NASDAQ), 38.35%
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 34.89%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 33.67%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 32.82%
- Emclaire Financial Corp (EMCF:NASDAQ), 32.17%
- cbdMD, Inc. (YCBD:NYSEMKT), 31.33%
- NexImmune Inc. (NEXI:NASDAQ), 31.06%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 30.48%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 29.51%